Related references
Note: Only part of the references are listed.BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology
Camille Bigenwald et al.
NATURE MEDICINE (2021)
Transcriptomic Landscape of Circulating Mononuclear Phagocytes in Langerhans Cell Histiocytosis at Single-cell Level
Hui Shi et al.
BLOOD (2021)
Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells
Karen Phaik Har Lim et al.
BLOOD ADVANCES (2020)
Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition
Olive S. Eckstein et al.
BLOOD (2019)
Efficacy of MEK inhibition in patients with histiocytic neoplasms
Eli L. Diamond et al.
NATURE (2019)
Epigenomics and Singe-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis
Florian Halbritter et al.
CANCER DISCOVERY (2019)
Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study
Jean Donadieu et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions
Brandon Hogstad et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Langerhans-Cell Histiocytosis
Carl E. Allen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups
Marie-Luise Berres et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Share Paper
